Expression and characterization of SARS-CoV-2 proteins using recombinant vaccinia virus MVA-T7pol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2022
- Keyword
-
SARS-CoV-2
Coronaviren
COVID-19
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2022
- Creator
- Contributor
-
Sutter, Gerd
- DOI
-
10.5282/edoc.30480
- URN
-
urn:nbn:de:bvb:19-304809
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nan, Liangliang
- Sutter, Gerd
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2022
Other Objects (12)
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
Large-scale recombinant production of the SARS-CoV-2 proteome for high-throughput and structural biology applications
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
Large-scale recombinant production of the SARS-CoV-2 proteome for high-throughput and structural biology applications
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
In vivo evaluation of recombinant Vaccinia virus MVA delivering ancestral H9 hemagglutinin antigen of Avian Influenza virus
Recombinant modified Vaccinia Virus Ankara (MVA) vaccines efficiently protect cockatiels against parrot bornavirus infection and proventricular dilatation disease
SARS-CoV-2-Arbeitsschutzstandard
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
SARS-CoV-2 und Medikamenten
Coronavirus - COVID-19 - SARS-COV-2
Coronavirus - COVID-19 - SARS-COV-2
Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications
Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
Large-scale recombinant production of the SARS-CoV-2 proteome for high-throughput and structural biology applications